792 followers
A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer https://t.co/dbIjFNuAx7
A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer https://t.co/dbIjFNuAx7
'A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer' an article on #ScienceOpen: https://t.co/BjnZcC26EP @DovePress #OpenAccess